We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.15 | -0.16% | 91.67 | 91.53 | 91.90 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 92.28 | 91.41 | 91.41 | 1,378,404 | 16:40:00 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/11/2024 | 13:11 | UKREG | Sanofi: Informations relatives au nombre de droits de vote et d'actions -.. |
| 20/11/2024 | 13:11 | UKREG | Sanofi: Information concerning the total number of voting rights and shares.. |
| 15/11/2024 | 06:00 | UKREG | Communiqué de presse : La FDA a accepté l’examen de la sBLA pour le.. |
| 15/11/2024 | 06:00 | UKREG | Press Release: Dupixent sBLA accepted for FDA review for the treatment of.. |
| 14/11/2024 | 16:42 | UKREG | Communiqué de presse : Sarclisa : approbation recommandée par le CHMP dans.. |
| 14/11/2024 | 16:42 | UKREG | Press Release: Sarclisa recommended for EU approval by the CHMP to treat.. |
| 06/11/2024 | 06:00 | UKREG | Press Release: Dupixent approved in the EU as the first and only medicine.. |
| 06/11/2024 | 06:00 | UKREG | Communiqué de presse : Dupixent, premier et seul médicament approuvé dans.. |
| 25/10/2024 | 05:30 | UKREG | Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue.. |
| 25/10/2024 | 05:30 | UKREG | Press Release: Sanofi Q3: 15.7% sales growth boosted by.. |
1 Year Sanofi Chart |
Intraday Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
